← Leaderboards
Jason R Gotlib
Stanford University
$602,175
Attributed
$609,675
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $118.9K · FY2005–19$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$609,675 · 2
By mechanism
K23$594,675 · 1
R13$15,000 · 1
Top collaborators
- Cem Akin1 shared
Most similar at Stanford University
Same institution · by research overlap
- Irving Lerner Weissman$56,491,773
- Anandi Krishnan$1,190,205
- Daniel Bernstein$12,897,102
- Elif Seda Selamet Tierney$1,183,875
- Latha P Palaniappan$11,769,093
Others in their field
Top investigators on “Chronic Myelogenous Leukemia”
- David Heimbrook · Leidos Biomedical Research, Inc.$50,670,591
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Emmanuelle Passegue · University Of California, San Francisco$10,654,159
- Michael A Caligiuri · Ohio State University$10,068,919
- Ravi Bhatia · University Of Alabama At Birmingham$9,913,654
- Brian J Druker · Oregon Health And Science University$9,654,873
Research focus
Chronic Myelogenous LeukemiaDrug Screening /EvaluationClinical Trial Phase INeoplasm /Cancer TherapyDrug Adverse EffectDrug Administration Rate /DurationSingle Strand Conformation PolymorphismSds Polyacrylamide Gel ElectrophoresisHuman SubjectHuman Therapy EvaluationPatient Oriented ResearchPolymerase Chain ReactionEnzyme InhibitorsBlood ChemistryHyperplasiaCytogeneticsBone Marrow DisorderMyeloproliferative NeoplasmAlkyltransferaseEnzyme TherapyClinical ResearchBiologyAmericasBiological
Grant awards (6)
American Initiative in Mast Cell Diseases (AIM)$15,000
R13 · FY2019 · TR · contact PI
FTI Biology &Treatment of Myeloproliferative Disorders$118,935
K23 · FY2005 · HL
FTI Biology &Treatment of Myeloproliferative Disorders$118,935
K23 · FY2004 · HL
FTI Biology &Treatment of Myeloproliferative Disorders$118,935
K23 · FY2003 · HL
FTI Biology &Treatment of Myeloproliferative Disorders$118,935
K23 · FY2002 · HL
FTI Biology &Treatment of Myeloproliferative Disorders$118,935
K23 · FY2001 · HL